Cognex Corporation (NASDAQ:CGNX) Q2 2019 Earnings Conference Call July 29, 2019 5:00 PM ET
Company Participants
Susan Conway - Head of Investor Relations
Robert Shillman - Chairman
Robert Willett - Chief Executive Officer
Laura MacDonald - Vice President and Corporate Controller
Christopher Stagno - Treasurer
Conference Call Participants
Karen Lau - Gordon Haskett
Andrew Buscaglia - Joh. Berenberg, Gossler & Co.
Joseph Ritchie - Goldman Sachs & Co. LLC
Joseph Giordano - Cowen and Company, LLC
Richard Eastman - Robert W. Baird & Co.,
Joshua Pokrzywinski - Morgan Stanley
Michael Cikos - Needham & Company, LLC
Matt Summerville - D.A. Davidson & Co.
Jairam Nathan - Daiwa Securities Co. Ltd.
Ben Rose - Battle Road Research Ltd.
Paul Chung - JPMorgan Securities LLC
Operator
Greetings, and welcome to Cognex' Second Quarter 2019 Earnings Conference Call. As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Ms. Susan Conway, Cognex' Senior Director of Investor Relations. Thank you, Ms. Conway, you may begin.
Susan Conway
Thank you, and good evening, everyone. With us today are Cognex's Chairman, Dr. Bob Shillman; President and CEO, Rob Willett; Vice President and Corporate Controller, Laura MacDonald, and Cognex's Treasurer, Chris Stagno.
I'd like to point out that our earnings release, and quarterly report on Form 10-Q are available on the Investor Information section of our website at www.cognex.com. Those contain highly detailed information about our financial results.
During the call, we may use a non-GAAP financial measure if we believe it is useful to investors or if we believe it will help investors better understand our results or business trends. You can see a reconciliation of certain items from GAAP to non-GAAP in Exhibit 2 of the earnings release.
Any forward-looking statements we made in the earnings release or any that we may make during this call are based upon information that we believe to be true as of today. Things often change however and actual results may differ materially from those projected or anticipated. You should refer to our SEC filings, including our most recent Form 10-K for a detailed list of these risk factors.
With that I'd like to turn the call over to Dr. Bob Shillman.
